TY - JOUR
T1 - Risk factors of hippocampal sclerosis in the oldest old
T2 - The 90+ Study
AU - Trieu, Thomas
AU - Sajjadi, Seyed Ahmad
AU - Kawas, Claudia H.
AU - Nelson, Peter T.
AU - Corrada, María M.
N1 - Publisher Copyright:
© 2018 American Academy of Neurology.
PY - 2018/11/6
Y1 - 2018/11/6
N2 - Objective To examine the risk factors and comorbidities of hippocampal sclerosis (HS) in the oldest-old. Methods A total of 134 participants with dementia from The 90+ Study with longitudinal evaluations and autopsy were included in this investigation. Participants were divided into 2 groups, one with and one without HS pathology, and differences in clinical and pathologic characteristics were compared. Results Persons with HS tended to have a longer duration of dementia compared to participants without HS (mean 4.0 years vs 6.7 years, odds ratio [OR] 1.26; 95% confidence interval [CI] 1.11-1.42; p < 0.001). HS was more likely in participants with a history of autoimmune diseases (rheumatoid arthritis or thyroid disease, OR 3.15; 95% CI 1.30-7.62; p = 0.011), high thyroidstimulating hormone (OR 4.94; 95% CI 1.40-17.46; p = 0.013), or high thyroid antibodies (OR 3.45; 95% CI 1.09-10.88; p = 0.035). Lewy body disease (LBD) pathology was also associated with an increased likelihood of HS (OR 5.70; 95% CI 1.22-26.4; p = 0.027). Conclusion We identified autoimmune conditions (rheumatoid arthritis and thyroid disease) as potential risk factors for HS in our cohort. LBD was the only pathology that was associated with increased odds of HS and those harboring HS pathology had a longer duration of dementia. This suggests multiple pathways of HS pathology among the oldest-old.
AB - Objective To examine the risk factors and comorbidities of hippocampal sclerosis (HS) in the oldest-old. Methods A total of 134 participants with dementia from The 90+ Study with longitudinal evaluations and autopsy were included in this investigation. Participants were divided into 2 groups, one with and one without HS pathology, and differences in clinical and pathologic characteristics were compared. Results Persons with HS tended to have a longer duration of dementia compared to participants without HS (mean 4.0 years vs 6.7 years, odds ratio [OR] 1.26; 95% confidence interval [CI] 1.11-1.42; p < 0.001). HS was more likely in participants with a history of autoimmune diseases (rheumatoid arthritis or thyroid disease, OR 3.15; 95% CI 1.30-7.62; p = 0.011), high thyroidstimulating hormone (OR 4.94; 95% CI 1.40-17.46; p = 0.013), or high thyroid antibodies (OR 3.45; 95% CI 1.09-10.88; p = 0.035). Lewy body disease (LBD) pathology was also associated with an increased likelihood of HS (OR 5.70; 95% CI 1.22-26.4; p = 0.027). Conclusion We identified autoimmune conditions (rheumatoid arthritis and thyroid disease) as potential risk factors for HS in our cohort. LBD was the only pathology that was associated with increased odds of HS and those harboring HS pathology had a longer duration of dementia. This suggests multiple pathways of HS pathology among the oldest-old.
UR - http://www.scopus.com/inward/record.url?scp=85056269793&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056269793&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000006455
DO - 10.1212/WNL.0000000000006455
M3 - Article
C2 - 30315072
AN - SCOPUS:85056269793
SN - 0028-3878
VL - 91
SP - E1788-1798
JO - Neurology
JF - Neurology
IS - 19
ER -